A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Hosted on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ongoing battle against the virus. This breakthrough builds on a series of ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Grace VanderWaal may not be a ukulele-strumming wunderkind anymore, but her talent sparkles just the same. The singer-songwriter and former child star stole hearts on "America's Got Talent" nearly a ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The Cure surprised no one by returning from a 16-year hiatus better than ever. It is The Cure after all. The band’s 2024 release, Songs Of A Lost World, kicked off a new era for the group, with the ...
Gilead Sciences (NASDAQ:GILD) has discontinued a Phase 1 trial for GS-1219, a long-acting subcutaneously delivered treatment targeting HIV infections, according to an update on the federal register on ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Robin Lin Miller, Michigan State University (THE CONVERSATION) Protecting public ...
CURE spoke with Alexa M. Lantz of Penn State Health about radiation side effects. For patients with cancer who are receiving treatment with radiation therapy, keeping lines of communication open with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback